The physiology and clinical utility of anti-Mullerian hormone in 1 women 2

[1]  S. Franks,et al.  Genetics of polycystic ovary syndrome. , 2016, Frontiers of hormone research.

[2]  D. Cameron,et al.  Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer☆ , 2013, European journal of cancer.

[3]  N. Raine-Fenning,et al.  Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. , 2013, Molecular human reproduction.

[4]  S. Iliodromiti,et al.  Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. , 2013, The Journal of clinical endocrinology and metabolism.

[5]  R. Pierson,et al.  Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. , 2013, Human reproduction.

[6]  A. Ruokonen,et al.  Antimüllerian hormone levels decrease in women using combined contraception independently of administration route. , 2013, Fertility and sterility.

[7]  A. Erdem,et al.  Antral follicle count determines poor ovarian response better than anti-müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles , 2013, Journal of Assisted Reproduction and Genetics.

[8]  R. Fanchin,et al.  Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. , 2013, Human reproduction.

[9]  M. Solaymani-Dodaran,et al.  Modeling age at menopause using serum concentration of anti-mullerian hormone. , 2013, The Journal of clinical endocrinology and metabolism.

[10]  S. Nelson,et al.  Reproducibility of AMH. , 2012, Human reproduction.

[11]  J. Forman,et al.  Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. , 2012, Reproductive biomedicine online.

[12]  T. K. Jensen,et al.  Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study. , 2012, Fertility and sterility.

[13]  Richard A. Anderson,et al.  Correlation between three assay systems for anti-Müllerian hormone (AMH) determination , 2012, Journal of Assisted Reproduction and Genetics.

[14]  Richard A. Anderson,et al.  Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout life. , 2012, Fertility and sterility.

[15]  J. Visser,et al.  Limitations and pitfalls of antimüllerian hormone measurements. , 2012, Fertility and sterility.

[16]  A. Duhamel,et al.  Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea. , 2012, The Journal of clinical endocrinology and metabolism.

[17]  M. Sammel,et al.  Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. , 2012, Fertility and sterility.

[18]  C. Argento,et al.  Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle‐stimulating hormone starting dose in in vitro fertilisation cycles , 2012, BJOG : an international journal of obstetrics and gynaecology.

[19]  S. Fosså,et al.  Gonadal function and parenthood 20 years after treatment for childhood lymphoma: A cross‐sectional study , 2012, Pediatric blood & cancer.

[20]  E. Papaleo,et al.  Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[21]  B. Campbell,et al.  The role of anti-Müllerian hormone (AMH) during follicle development in a monovulatory species (sheep). , 2012, Endocrinology.

[22]  M. Metwally,et al.  The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[23]  R. Anderson,et al.  Data-driven assessment of the human ovarian reserve. , 2012, Molecular human reproduction.

[24]  A. Duhamel,et al.  Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. , 2011, Human reproduction.

[25]  W. Yeung,et al.  Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea. , 2011, Fertility and sterility.

[26]  A. McConnachie,et al.  External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients. , 2011, Reproductive biomedicine online.

[27]  S. Nelson,et al.  A multicentre evaluation of the new Beckman Coulter anti-Müllerian hormone immunoassay (AMH Gen II) , 2011, Annals of clinical biochemistry.

[28]  L. Gianaroli,et al.  ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. , 2011, Human reproduction.

[29]  S. Moon,et al.  Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits. , 2011, Fertility and sterility.

[30]  Richard A. Anderson,et al.  A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause , 2011, PloS one.

[31]  C. Gnoth,et al.  Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study. , 2011, Fertility and sterility.

[32]  D. Cameron,et al.  Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. , 2011, The Journal of clinical endocrinology and metabolism.

[33]  A. Volpe,et al.  Age-specific nomogram for the decline in antral follicle count throughout the reproductive period. , 2011, Fertility and sterility.

[34]  D. Lawlor,et al.  Predicting Live Birth, Preterm Delivery, and Low Birth Weight in Infants Born from In Vitro Fertilisation: A Prospective Study of 144,018 Treatment Cycles , 2011, PLoS medicine.

[35]  F. Broekmans,et al.  The antral follicle count: practical recommendations for better standardization. , 2010, Fertility and sterility.

[36]  Y. T. van der Schouw,et al.  Human studies on genetics of the age at natural menopause: a systematic review. , 2010, Human reproduction update.

[37]  H. Al-Inany,et al.  Effect of obesity on parameters of ovarian reserve in premenopausal women. , 2010, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[38]  G. Jones,et al.  Effect of cigarette smoking upon reproductive hormones in women of reproductive age: a retrospective analysis. , 2010, Reproductive biomedicine online.

[39]  J. Twisk,et al.  Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. , 2010, Human reproduction.

[40]  E. Ernst,et al.  Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles. , 2010, Human reproduction.

[41]  D. Baird,et al.  The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years , 2010, Menopause.

[42]  K. Dafopoulos,et al.  Smoking and AMH levels in women with normal reproductive history , 2010, Archives of Gynecology and Obstetrics.

[43]  F. Stanczyk,et al.  Antimullerian hormone and obesity: insights in oral contraceptive users. , 2010, Contraception.

[44]  Mardge H. Cohen,et al.  Variations in serum müllerian inhibiting substance between white, black, and Hispanic women. , 2009, Fertility and sterility.

[45]  M. Solaymani-Dodaran,et al.  A single test of antimüllerian hormone in late reproductive-aged women is a good predictor of menopause , 2009, Menopause.

[46]  Thomas W. Kelsey,et al.  Human Ovarian Reserve from Conception to the Menopause , 2009, PloS one.

[47]  R. Norman,et al.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. , 2009, Fertility and sterility.

[48]  O. Coll,et al.  Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. , 2009, Fertility and sterility.

[49]  C. Andersen,et al.  Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Müllerian hormone and inhibin-B. , 2008, Fertility and sterility.

[50]  R. Rey,et al.  Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. , 2007, The Journal of clinical endocrinology and metabolism.

[51]  R. Pieters,et al.  Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. , 2007, The Journal of clinical endocrinology and metabolism.

[52]  S. Nelson,et al.  Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy. , 2007, Human reproduction.

[53]  M. Skinner,et al.  Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. , 2007, Reproduction.

[54]  Y. Englert,et al.  Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. , 2007, Human reproduction.

[55]  A. Volpe,et al.  The Anti-Mullerian hormone and ovarian cancer. , 2007, Human reproduction update.

[56]  E. R. van den Heuvel,et al.  Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice. , 2007, Endocrinology.

[57]  L. Nardo,et al.  Anti-Müllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: Relationship to lifestyle factors, chronological age and reproductive history , 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[58]  A. Byskov,et al.  Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid. , 2006, The Journal of clinical endocrinology and metabolism.

[59]  J. Stark,et al.  Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. , 2005, The Journal of clinical endocrinology and metabolism.

[60]  I. Gigli,et al.  Evidence for a role for anti‐Müllerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane , 2005, Molecular reproduction and development.

[61]  J. Visser,et al.  Anti-Müllerian hormone and folliculogenesis , 2005, Molecular and Cellular Endocrinology.

[62]  A. Byskov,et al.  Anti-Müllerian hormone initiates growth of human primordial follicles in vitro , 2005, Molecular and Cellular Endocrinology.

[63]  A. Handyside,et al.  Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice. , 2004, Developmental biology.

[64]  B. Fauser,et al.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. , 2004, Molecular human reproduction.

[65]  D. Dewailly,et al.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. , 2003, The Journal of clinical endocrinology and metabolism.

[66]  Didier Dewailly,et al.  Ultrasound assessment of the polycystic ovary: international consensus definitions. , 2003, Human reproduction update.

[67]  R. Anderson,et al.  Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. , 2003, Human reproduction.

[68]  J. Stark,et al.  Formation and early development of follicles in the polycystic ovary , 2003, The Lancet.

[69]  J. Visser,et al.  Regulation of ovarian function: the role of anti-Müllerian hormone. , 2002, Reproduction.

[70]  M. Matzuk,et al.  Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary. , 2001, Endocrinology.

[71]  J. Bidart,et al.  Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. , 2000, Human pathology.

[72]  J. Bidart,et al.  Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. , 2000, The Journal of clinical endocrinology and metabolism.

[73]  N. Skakkebaek,et al.  Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. , 1999, The Journal of clinical endocrinology and metabolism.

[74]  A. Gougeon.  Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. , 1998, Maturitas.

[75]  H. Ingraham,et al.  Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[76]  P. Kramer,et al.  Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. , 1995, Endocrinology.

[77]  P. Donahoe,et al.  Mullerian inhibiting substance: a gonadal hormone with multiple functions. , 1993, Endocrine reviews.

[78]  M. Forest,et al.  Anti-Müllerian hormone produces endocrine sex reversal of fetal ovaries. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[79]  P. Donahoe,et al.  The ontogeny of mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle. , 1986, Biology of reproduction.

[80]  J. Picard,et al.  Purification of testicular anti-Müllerian hormone allowing direct visualization of the pure glycoprotein and determination of yield and purification factor , 1984, Molecular and Cellular Endocrinology.

[81]  P. Donahoe,et al.  The ontogeny of Mullerian inhibiting substance in the gonads of the chicken. , 1981, Journal of pediatric surgery.

[82]  A. Jost.  The Age Factor in the Castration of Male Rabbit Fetuses , 1947, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[83]  J. Stockman.  Effect of age on decisions about the numbers of embryos to transfer in assisted conception: a prospective study , 2013 .

[84]  S. Nelsonb,et al.  Measuring anti-Müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated? , 2012, Maturitas.

[85]  L. Natarajan,et al.  Impact of breast cancer on anti-mullerian hormone levels in young women , 2012, Breast Cancer Research and Treatment.

[86]  V. Padmanabhan,et al.  Developmental Programming: Impact of Excess Prenatal Testosterone on Intrauterine Fetal Endocrine Milieu and Growth in Sheep1 , 2011, Biology of reproduction.

[87]  A. Meikle.  Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles , 2011 .

[88]  N. Knowlton,et al.  Correlation of ovarian reserve tests with histologically determined primordial follicle number. , 2011, Fertility and sterility.

[89]  M. Eijkemans,et al.  Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. , 2010, Human reproduction.

[90]  P. Bischof,et al.  Clinical uses of anti-Müllerian hormone assays: pitfalls and promises. , 2009, Fertility and sterility.

[91]  M. Denis,et al.  Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). , 2007, Clinica chimica acta; international journal of clinical chemistry.

[92]  S. Whitehead,et al.  Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. , 2007, The Journal of clinical endocrinology and metabolism.

[93]  D. Baird,et al.  Inhibin and related peptides in the regulation of reproduction. , 1993, Oxford reviews of reproductive biology.

[94]  J. Hutson,et al.  Serum levels of müllerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay. , 1990, The Journal of clinical endocrinology and metabolism.